NSE - Delayed Quote INR

Tatva Chintan Pharma Chem Limited (TATVA.NS)

1,643.90 +29.10 (+1.80%)

At close: October 30 at 3:30:01 PM GMT+5:30

Chart Range Bar

Loading chart for TATVA.NS

Previous Close 1,614.80
Open 1,624.90
Bid --
Ask --
Day's Range 1,582.10 - 1,659.00
52 Week Range 1,044.10 - 2,113.60
Volume 73,962
Avg. Volume 94,315
Market Cap (intraday) 38.454B
Beta (5Y Monthly) 0.30
PE Ratio (TTM) 61.11
EPS (TTM) 26.90
Earnings Date --
Forward Dividend & Yield 2.00 (0.12%)
Ex-Dividend Date Sep 11, 2026
1y Target Est 1,550.00

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, consumer electronics, pharmaceutical, agrochemicals, paints and coatings, dyes, and personal care sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.

www.tatvachintan.com

793

Full Time Employees

March 31

Fiscal Year Ends

Basic Materials

Sector

Specialty Chemicals

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

TATVA.NS

23.36%

S&P BSE SENSEX (^BSESN)

12.63%

1-Year Return

TATVA.NS

21.04%

S&P BSE SENSEX (^BSESN)

11.78%

3-Year Return

TATVA.NS

8.92%

S&P BSE SENSEX (^BSESN)

16.14%

5-Year Return

TATVA.NS

33.96%

S&P BSE SENSEX (^BSESN)

25.55%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY27

Revenue 2.17B

Earnings 214.51M

Profit Margin 9.87%

FY26

FY27

500M

8.0%

9.0%

10.0%

11.0%

Analyst Price Targets

835.00 Low

1,550.00 Average

1,643.90 Current

2,385.00 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

9.68%
Return on Assets (ttm)

5.50%
Return on Equity (ttm)

8.02%
Revenue (ttm)

6.5B
Net Income Avi to Common (ttm)

629.18M
Diluted EPS (ttm)

26.90

Balance Sheet and Cash Flow

Total Cash (mrq)

152.05M
Total Debt/Equity (mrq)

20.87%
Levered Free Cash Flow (ttm)

-1.1B

CLEAN.NS Clean Science and Technology Limited

715.60 -3.32%

LXCHEM.NS Laxmi Organic Industries Limited

152.74 -4.52%

ACUTAAS.NS Acutaas Chemicals Limited

4,003.60 +0.68%

NEOGEN.NS Neogen Chemicals Limited

2,171.40 -3.99%

ROSSARI.NS Rossari Biotech Limited

399.25 -2.05%

U.S. markets closed

Tatva Chintan Pharma Chem Limited (TATVA.NS)

4.75%

-7.86%

25.39%

23.21%

20.89%

-34.38%

-22.16%

Tatva Chintan Pharma Chem Limited Overview Specialty Chemicals / Basic Materials

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch